| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/STEM.1293 |
| P698 | PubMed publication ID | 23193063 |
| P50 | author | Shinya Yamanaka | Q80917 |
| Keisuke Okita | Q73389625 | ||
| Tatsuya Yamakawa | Q125315814 | ||
| Yasuko Matsumura | Q125315938 | ||
| Naoki Amano | Q125316166 | ||
| Naoki Goshima | Q125316275 | ||
| P2093 | author name string | Akira Watanabe | |
| Yoshiko Sato | |||
| P2860 | cites work | Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization | Q24292930 |
| Disease-specific induced pluripotent stem cells | Q24641981 | ||
| Direct cell reprogramming is a stochastic process amenable to acceleration | Q24644898 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization | Q28243346 | ||
| Reprogramming of human somatic cells to pluripotency with defined factors | Q28262710 | ||
| The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain | Q28586297 | ||
| Wnt signaling promotes reprogramming of somatic cells to pluripotency | Q28741624 | ||
| Efficient feeder-free episomal reprogramming with small molecules | Q28742307 | ||
| Generation of induced pluripotent stem cells from CD34+ cells across blood drawn from multiple donors with non-integrating episomal vectors | Q28742368 | ||
| A framework for variation discovery and genotyping using next-generation DNA sequencing data | Q29547262 | ||
| Human induced pluripotent stem cells free of vector and transgene sequences | Q29547624 | ||
| Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes | Q29614341 | ||
| A more efficient method to generate integration-free human iPS cells | Q29615748 | ||
| Somatic coding mutations in human induced pluripotent stem cells | Q29616798 | ||
| High-frequency transformation of human repair-deficient cell lines by an Epstein-Barr virus-based cDNA expression vector | Q33239612 | ||
| Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders | Q33560423 | ||
| Tbx3 improves the germ-line competency of induced pluripotent stem cells | Q33983679 | ||
| Reprogramming of T cells from human peripheral blood | Q34034432 | ||
| Reprogramming of human peripheral blood cells to induced pluripotent stem cells | Q34048915 | ||
| Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. | Q34191072 | ||
| Multiple targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced pluripotent stem cells | Q36937559 | ||
| Generation of induced pluripotent stem cells from human blood | Q37209041 | ||
| Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells | Q37337807 | ||
| Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures | Q38706487 | ||
| Rem2 GTPase maintains survival of human embryonic stem cells as well as enhancing reprogramming by regulating p53 and cyclin D1. | Q39691123 | ||
| Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts | Q39977218 | ||
| A simple and efficient cryopreservation method for primate embryonic stem cells. | Q40480253 | ||
| Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency | Q42811272 | ||
| Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts | Q47707965 | ||
| Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. | Q51902673 | ||
| Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. | Q51942778 | ||
| Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. | Q54420423 | ||
| Two Supporting Factors Greatly Improve the Efficiency of Human iPSC Generation | Q57974225 | ||
| T cell stimulation and expansion using anti-CD3/CD28 beads | Q73197893 | ||
| Early TCR expression and aberrant T cell development in mice with endogenous prerearranged T cell receptor genes | Q80582209 | ||
| P4510 | describes a project that uses | 585A1 | Q54603888 |
| 585B1 | Q54603890 | ||
| 604A1 | Q54604230 | ||
| 604B1 | Q54604318 | ||
| 648A1 | Q54604387 | ||
| 648B1 | Q54604388 | ||
| 692D2 | Q54604497 | ||
| 692E1 | Q54604498 | ||
| P433 | issue | 3 | |
| P921 | main subject | cell line | Q21014462 |
| Human Induced Pluripotent Stem Cells | Q88981775 | ||
| P304 | page(s) | 458-466 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells | |
| P478 | volume | 31 |
| Q36126444 | A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells |
| Q42677230 | A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells |
| Q35087542 | A comparison of non-integrating reprogramming methods |
| Q50118902 | A defined culture method enabling the establishment of ring sideroblasts from induced pluripotent cells of X-linked sideroblastic anemia |
| Q35200170 | A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach |
| Q28116910 | A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia |
| Q41857309 | A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells |
| Q50074642 | ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells. |
| Q57784395 | Abstract |
| Q47137465 | Adrenergic receptor agonists induce the differentiation of pluripotent stem cell-derived hepatoblasts into hepatocyte-like cells |
| Q34850388 | Adult somatic cells to the rescue: nuclear reprogramming and the dispensability of gonadal germ cells. |
| Q34601924 | Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells |
| Q35653333 | Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells |
| Q38187715 | All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. |
| Q47940875 | Allele-specific ablation rescues electrophysiological abnormalities in a human iPS cell model of long-QT syndrome with a CALM2 mutation |
| Q39305636 | Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts |
| Q35770646 | An HDAC2-TET1 switch at distinct chromatin regions significantly promotes the maturation of pre-iPS to iPS cells |
| Q90432163 | An Integrated Approach toward the Biomanufacturing of Engineered Cell Therapy Products in a Stirred-Suspension Bioreactor |
| Q26775122 | An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs |
| Q41715825 | Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs |
| Q57150066 | Application of Cord Blood and Cord Blood-derived Induced Pluripotent Stem Cells for Cartilage Regeneration |
| Q35575856 | Biology and mechano-response of tendon cells: Progress overview and perspectives |
| Q64891859 | CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies. |
| Q47141460 | CHARGE syndrome modeling using patient-iPSCs reveals defective migration of neural crest cells harboring CHD7 mutations. |
| Q37324286 | Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons |
| Q21195758 | Cardiac regeneration and diabetes |
| Q38791791 | Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates |
| Q34044521 | Cell Therapy Using Human Induced Pluripotent Stem Cell-Derived Renal Progenitors Ameliorates Acute Kidney Injury in Mice |
| Q34259132 | Cell signalling pathways underlying induced pluripotent stem cell reprogramming |
| Q55394827 | Cell therapy for severe burn wound healing. |
| Q40018834 | Cellular Ontogeny and Hierarchy Influence the Reprogramming Efficiency of Human B Cells into Induced Pluripotent Stem Cells. |
| Q38141509 | Cellular reprogramming of human peripheral blood cells |
| Q42087648 | Characterization of Mesenchymal Stem Cell-Like Cells Derived From Human iPSCs via Neural Crest Development and Their Application for Osteochondral Repair. |
| Q91233080 | Characterization of a small molecule that promotes cell cycle activation of human induced pluripotent stem cell-derived cardiomyocytes |
| Q90254830 | Chemically defined and growth-factor-free culture system for the expansion and derivation of human pluripotent stem cells |
| Q37706589 | Chick stem cells: current progress and future prospects |
| Q28085565 | Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies |
| Q50027186 | Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitors |
| Q38255414 | Clinically relevant aspects of stem cell technologies: current state of play |
| Q28081651 | Concise Review: Exciting Cells: Modeling Genetic Epilepsies with Patient-Derived Induced Pluripotent Stem Cells |
| Q37680999 | Concise review: drug discovery in the age of the induced pluripotent stem cell |
| Q93115886 | Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells |
| Q92039578 | Congenital pituitary hypoplasia model demonstrates hypothalamic OTX2 regulation of pituitary progenitor cells |
| Q38372922 | Current advances in the generation of human iPS cells: implications in cell-based regenerative medicine. |
| Q38287660 | Current methods and challenges in the comprehensive characterization of human pluripotent stem cells. |
| Q35002134 | Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast |
| Q36179402 | Derivation of Patient Specific Pluripotent Stem Cells Using Clinically Discarded Cumulus Cells |
| Q58778293 | Derivation of induced pluripotent stem cells in Japanese macaque (Macaca fuscata) |
| Q51010111 | Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System. |
| Q54965268 | Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. |
| Q98237949 | Developmental excitation-inhibition imbalance underlying psychoses revealed by single-cell analyses of discordant twins-derived cerebral organoids |
| Q28973606 | Differences and similarities between human and chimpanzee neural progenitors during cerebral cortex development |
| Q50163149 | Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells |
| Q42072961 | Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate |
| Q38807015 | Directed Induction of Functional Multi-ciliated Cells in Proximal Airway Epithelial Spheroids from Human Pluripotent Stem Cells. |
| Q34039059 | Directed cardiomyogenesis of autologous human induced pluripotent stem cells recruited to infarcted myocardium with bioengineered antibodies |
| Q92035077 | Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium |
| Q48042024 | Discordant congenital Zika syndrome twins show differential in vitro viral susceptibility of neural progenitor cells |
| Q48249330 | EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome |
| Q41271475 | Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition between iPS cell and neural stem cell stages |
| Q35679665 | Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells |
| Q58701290 | Efficient derivation of sympathetic neurons from human pluripotent stem cells with a defined condition |
| Q38845030 | Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism |
| Q34738075 | Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors |
| Q38235439 | Emerging trends and new developments in regenerative medicine: a scientometric update (2000 - 2014). |
| Q92255578 | End-to-End Platform for Human Pluripotent Stem Cell Manufacturing |
| Q37014686 | Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors |
| Q36442713 | Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes |
| Q41154014 | Enhanced generation of iPSCs from older adult human cells by a synthetic five-factor self-replicative RNA. |
| Q36885838 | Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins |
| Q60301825 | Estimating the concentration of therapeutic range using disease-specific iPS cells: Low-dose rapamycin therapy for Pendred syndrome |
| Q93180380 | Evaluation of commonly used ectoderm markers in iPSC trilineage differentiation |
| Q90927831 | Ex vivo generation of transfusable red blood cells from various stem cell sources: A concise revisit of where we are now |
| Q33413336 | Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells |
| Q64238091 | Expression of Lin28 is correlated with prognosis and expression of HER-2 and steroid receptors in breast cancer |
| Q89983929 | Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing |
| Q34661781 | Few single nucleotide variations in exomes of human cord blood induced pluripotent stem cells |
| Q37272419 | First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine |
| Q36678789 | Functional Neurons Generated from T Cell-Derived Induced Pluripotent Stem Cells for Neurological Disease Modeling |
| Q64074394 | Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cells |
| Q90503375 | Generation of Fabry cardiomyopathy model for drug screening using induced pluripotent stem cell-derived cardiomyocytes from a female Fabry patient |
| Q41064414 | Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions |
| Q42005669 | Generation of Integration-free Human Induced Pluripotent Stem Cells Using Hair-derived Keratinocytes |
| Q40366638 | Generation of Integration-free Induced Pluripotent Stem Cells from Human Peripheral Blood Mononuclear Cells Using Episomal Vectors |
| Q48365947 | Generation of Transplantable Retinal Photoreceptors from a Current Good Manufacturing Practice-Manufactured Human Induced Pluripotent Stem Cell Line. |
| Q47377037 | Generation of a Motor Nerve Organoid with Human Stem Cell-Derived Neurons |
| Q92230955 | Generation of a human induced pluripotent stem cell line, BRCi001-A, derived from a patient with mucopolysaccharidosis type I |
| Q34699730 | Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells |
| Q35891638 | Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system |
| Q100761930 | Generation of human induced pluripotent stem cell-derived liver buds with chemically defined and animal origin-free media |
| Q90819402 | Generation of infant- and pediatric-derived urinary induced pluripotent stem cells competent to form kidney organoids |
| Q36209829 | Generation of integration-free induced hepatocyte-like cells from mouse fibroblasts |
| Q52699089 | Generation of safe and therapeutically effective human induced pluripotent stem cell-derived hepatocyte-like cells for regenerative medicine. |
| Q48449614 | Genetic and pharmacological correction of aberrant dopamine synthesis using patient iPSCs with BH4 metabolism disorders |
| Q92394646 | Genomic Instability of iPSCs and Challenges in Their Clinical Applications |
| Q38945910 | Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications |
| Q87854899 | Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack |
| Q37535262 | High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia |
| Q92901896 | Highly efficient induced pluripotent stem cell reprogramming of cryopreserved lymphoblastoid cell lines |
| Q38874111 | Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine. |
| Q37272276 | Human Skin Constructs with Spatially Controlled Vasculature Using Primary and iPSC-Derived Endothelial Cells |
| Q30577389 | Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking. |
| Q48132718 | Human iPS cell-derived dopaminergic neurons function in a primate Parkinson's disease model. |
| Q37253750 | Human iPSC-derived neural crest stem cells promote tendon repair in a rat patellar tendon window defect model |
| Q48268667 | Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure. |
| Q33788845 | Human stem cells for craniomaxillofacial reconstruction. |
| Q91923099 | Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons |
| Q48294409 | Idiopathic Parkinson's disease patient-derived induced pluripotent stem cells function as midbrain dopaminergic neurons in rodent brains. |
| Q90196682 | In Vitro Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of PCDH15 and RELN |
| Q27300744 | In vitro characterization of neurite extension using induced pluripotent stem cells derived from lissencephaly patients with TUBA1A missense mutations |
| Q57454780 | Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development |
| Q38110478 | Induced neural stem cells (iNSCs) in neurodegenerative diseases |
| Q38167806 | Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery. |
| Q34036938 | Induced pluripotent stem cells in medicine and biology |
| Q36087743 | Induction of artificial cancer stem cells from tongue cancer cells by defined reprogramming factors |
| Q36285923 | Induction of hair follicle dermal papilla cell properties in human induced pluripotent stem cell-derived multipotent LNGFR(+)THY-1(+) mesenchymal cells |
| Q26830425 | Induction of pluripotency by defined factors |
| Q98665104 | Inositol monophosphatase 1 (IMPA1) mutation in intellectual disability patients impairs neurogenesis but not gliogenesis |
| Q38130450 | Is aging a barrier to reprogramming? Lessons from induced pluripotent stem cells |
| Q35453993 | KLF4 N-terminal variance modulates induced reprogramming to pluripotency |
| Q37274084 | L-MYC Expression Maintains Self-Renewal and Prolongs Multipotency of Primary Human Neural Stem Cells |
| Q38820014 | Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors |
| Q37662103 | Laminin modification subretinal bio-scaffold remodels retinal pigment epithelium-driven microenvironment in vitro and in vivo |
| Q42777921 | Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. |
| Q26995280 | Mechanisms and models of endoplasmic reticulum stress in chondrodysplasia |
| Q38332490 | Methods of induced pluripotent stem cells for clinical application |
| Q37084919 | Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes |
| Q38666481 | Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells |
| Q52960326 | Modeling Drug-Induced Neuropathy Using Human iPSCs for Predictive Toxicology. |
| Q93038643 | Modeling genetic epilepsies in a dish |
| Q41680408 | Modelling human development and disease in pluripotent stem-cell-derived gastric organoids |
| Q46159490 | Molecular and cellular reorganization of neural circuits in the human lineage. |
| Q52966119 | Molecular mechanisms of induced pluripotency. |
| Q91741636 | Multimodal Therapeutic Effects of Neural Precursor Cells Derived from Human-Induced Pluripotent Stem Cells through Episomal Plasmid-Based Reprogramming in a Rodent Model of Ischemic Stroke |
| Q89944639 | Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies |
| Q30838313 | Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability. |
| Q89936436 | N-Terminal Amino Acids Determine KLF4 Protein Stability in 2A Peptide-Linked Polycistronic Reprogramming Constructs |
| Q98568495 | NLRP7 plays a functional role in regulating BMP4 signaling during differentiation of patient-derived trophoblasts |
| Q35494890 | New type of Sendai virus vector provides transgene-free iPS cells derived from chimpanzee blood |
| Q26861483 | Non-viral methods for generating integration-free, induced pluripotent stem cells |
| Q93335383 | Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration |
| Q47598499 | Nonintegrating Human Somatic Cell Reprogramming Methods |
| Q42050335 | Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction. |
| Q64060127 | Optical Recording of Action Potentials in Human Induced Pluripotent Stem Cell-Derived Cardiac Single Cells and Monolayers Generated from Long QT Syndrome Type 1 Patients |
| Q27015774 | Optimization of pre-transplantation conditions to enhance the efficacy of mesenchymal stem cells |
| Q55452593 | Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood. |
| Q90754750 | Organoid single-cell genomic atlas uncovers human-specific features of brain development |
| Q63740160 | Organs to Cells and Cells to Organoids: The Evolution of Central Nervous System Modelling |
| Q91965003 | Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods |
| Q53492109 | Overview of the Moral Status of iPS Cells. |
| Q90577088 | Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes |
| Q48028186 | Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium |
| Q90205326 | Pathological Progression Induced by the Frontotemporal Dementia-Associated R406W Tau Mutation in Patient-Derived iPSCs |
| Q37264786 | Pathological classification of human iPSC-derived neural stem/progenitor cells towards safety assessment of transplantation therapy for CNS diseases |
| Q37126951 | Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa |
| Q93098955 | Phenotypic Drug Screening for Dysferlinopathy Using Patient-Derived Induced Pluripotent Stem Cells |
| Q35582332 | Placenta-based therapies for the treatment of epidermolysis bullosa |
| Q64082878 | Plasmid-based generation of neural cells from human fibroblasts using non-integrating episomal vectors |
| Q99248457 | Pluripotent stem cell model of Shwachman-Diamond syndrome reveals apoptotic predisposition of hemoangiogenic progenitors |
| Q34045087 | Practical Integration-Free Episomal Methods for Generating Human Induced Pluripotent Stem Cells |
| Q92465640 | Profiling of lincRNAs in human pluripotent stem cell derived forebrain neural progenitor cells |
| Q99237786 | Propranolol Attenuates Late Sodium Current in a Long QT Syndrome Type 3-Human Induced Pluripotent Stem Cell Model |
| Q37642955 | Proteasome impairment in neural cells derived from HMSN-P patient iPSCs |
| Q102369222 | Quantitative proteomics reveal lineage-specific protein profiles in iPSC-derived Marfan syndrome smooth muscle cells |
| Q38121503 | RNA-based tools for nuclear reprogramming and lineage-conversion: towards clinical applications. |
| Q93066191 | Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies |
| Q34184553 | Recent technological updates and clinical applications of induced pluripotent stem cells |
| Q50140936 | Reciprocity of Action of Increasing Oct4 and Repressing p53 in Transdifferentiation of Mouse Embryonic Fibroblasts into Cardiac Myocytes |
| Q93066314 | Recognition of, interest in, and understanding of induced pluripotent stem cells and regenerative medicine in Japanese students |
| Q38632891 | Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency |
| Q40394357 | Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα. |
| Q90212627 | Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes |
| Q47210326 | Reprogramming of Adult Peripheral Blood Cells into Human Induced Pluripotent Stem Cells as a Safe and Accessible Source of Endothelial Cells |
| Q36587892 | Reprogramming of blood cells into induced pluripotent stem cells as a new cell source for cartilage repair |
| Q35789597 | Reprogramming patient-derived cells to study the epilepsies |
| Q28083235 | Retinal pigment epithelium transplantation: concepts, challenges, and future prospects |
| Q48352444 | Risk of HLA Homozygous Cord Blood Transplantation: Implications for Induced Pluripotent Stem Cell Banking and Transplantation. |
| Q40720742 | Robust In Vitro Induction of Human Germ Cell Fate from Pluripotent Stem Cells |
| Q42400918 | SC3-seq: a method for highly parallel and quantitative measurement of single-cell gene expression. |
| Q36059427 | Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency |
| Q27324311 | Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes |
| Q28087290 | Signaling Pathways and Gene Regulatory Networks in Cardiomyocyte Differentiation |
| Q36930948 | Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa |
| Q35074117 | Small molecule screening in human induced pluripotent stem cell-derived terminal cell types |
| Q28085602 | Somatic cell nuclear transfer: origins, the present position and future opportunities |
| Q28082268 | Stem Cells: Potential Therapy for Neonatal Injury? |
| Q36988863 | Stem cell therapeutic possibilities: future therapeutic options for male-factor and female-factor infertility? |
| Q52431369 | Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system. |
| Q28066087 | Techniques of Human Embryonic Stem Cell and Induced Pluripotent Stem Cell Derivation |
| Q47714809 | The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. |
| Q38882417 | The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation |
| Q38929394 | The other side of the coin: Leveraging Epstein-Barr virus in research and therapy |
| Q58705271 | The pathogenesis linked to coenzyme Q10 insufficiency in iPSC-derived neurons from patients with multiple-system atrophy |
| Q110698644 | The pluripotent stem cell-specific transcript ESRG is dispensable for human pluripotency |
| Q38123370 | The use of stem cells for pancreatic regeneration in diabetes mellitus |
| Q36756232 | Tissue Engineering and Regenerative Medicine 2015: A Year in Review |
| Q38489289 | Toward stem cell-based phenotypic screens for neurodegenerative diseases |
| Q27319949 | Transdifferentiation-Induced Neural Stem Cells Promote Recovery of Middle Cerebral Artery Stroke Rats |
| Q38758515 | Transient Tcf3 Gene Repression by TALE-Transcription Factor Targeting |
| Q34699757 | Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage |
| Q34795607 | Treatment with retinoic acid and lens epithelial cell-conditioned medium in vitro directed the differentiation of pluripotent stem cells towards corneal endothelial cell-like cells |
| Q26798211 | Use of Adult Stem Cells for Cartilage Tissue Engineering: Current Status and Future Developments |
| Q35501343 | Use of human pluripotent stem cells to study and treat retinopathies |
| Q42949002 | Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells |
| Q58116145 | Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate |
| Q37023448 | Utility of Lymphoblastoid Cell Lines for Induced Pluripotent Stem Cell Generation |
| Q28655924 | Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature |
| Q92908774 | Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521 |
Search more.